Recovery Guide Intervention for Recurrent Psychiatric Hospitalization
NCT ID: NCT00400166
Last Updated: 2009-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2006-12-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REWRITALIZE Your Recovery - Evaluation of a Creative Writing Group Intervention
NCT06251908
Evaluation of a New Recovery-oriented Model of Psychiatric Inpatient Care
NCT06250296
Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis
NCT00307216
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
NCT00463346
Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial
NCT01936220
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Comparison(s): Recovery Guide services in addition to treatment as usual, compared to treatment as usual.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Recovery Mentor: peer-based supportive care
Recovery Mentor
Provided Recovery Mentor services
0
No Recovery Mentor, services as usual
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Recovery Mentor
Provided Recovery Mentor services
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently admitted in the Yale-New Haven Psychiatric Hospital (YNHPH)
* A history of two or more prior admissions within the past 18 months
* Proficient in the use of the English language
* A DSM-IV diagnosis of Schizophrenia, Schizoaffective Disorder, Psychotic Disorder NOS, or Major Depressive Disorder with Psychotic Features
Exclusion Criteria
* Primary DSM-IV diagnosis of substance abuse/dependence
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Connecticut State, Department of Mental Health and Addiction Services
OTHER_GOV
Eli Lilly and Company
INDUSTRY
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yale University School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William H Sledge, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale-New Haven Psychiatric Hospital
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
O'Connell MJ, Sledge WH, Staeheli M, Sells D, Costa M, Wieland M, Davidson L. Outcomes of a Peer Mentor Intervention for Persons With Recurrent Psychiatric Hospitalization. Psychiatr Serv. 2018 Jul 1;69(7):760-767. doi: 10.1176/appi.ps.201600478. Epub 2018 Apr 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0607001641
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.